|
Volumn 131, Issue 6, 2001, Pages 523-525
|
Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion
a b b a c d e |
Author keywords
Arrhythmias; Cannabinoid receptors; K + channels
|
Indexed keywords
5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE;
CANNABINOID 1 RECEPTOR;
CANNABINOID 2 RECEPTOR;
CANNABINOID RECEPTOR AFFECTING AGENT;
CANNABINOID RECEPTOR ANTAGONIST;
CHLORALOSE;
DEXANABINOL;
GLIBENCLAMIDE;
POTASSIUM CHANNEL;
POTASSIUM CHANNEL BLOCKING AGENT;
RIMONABANT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIARRHYTHMIC ACTIVITY;
ARRHYTHMOGENESIS;
ARTICLE;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENCY;
HEART INFARCTION;
HEART MUSCLE REPERFUSION;
HEART VENTRICLE ARRHYTHMIA;
INCIDENCE;
NONHUMAN;
RAT;
ANIMALS;
ANTI-ARRHYTHMIA AGENTS;
CANNABINOIDS;
CORONARY DISEASE;
HEART;
MYOCARDIAL REPERFUSION;
MYOCARDIAL REPERFUSION INJURY;
RATS;
RATS, WISTAR;
RECEPTORS, CANNABINOID;
RECEPTORS, DRUG;
TETRAHYDROCANNABINOL;
ANIMALIA;
|
EID: 0035683691
PISSN: 00074888
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1012381914518 Document Type: Article |
Times cited : (50)
|
References (14)
|